- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06402240
The Pocket Skills Adjunct Project
Feasibility, Acceptability, and Potential Efficacy of an Adjunct Digital Health Solution to Standard Dialectical Behavior Therapy
Study Overview
Status
Intervention / Treatment
Detailed Description
The purpose of this study is to evaluate the potential benefits of an optional add-on tool (i.e., an additional tool participants can use at the same time) alongside standard dialectical behavior therapy (DBT) group treatment (i.e., skills training). The adjunct tool is an online website that participants can use on any device connected to the internet and is also based on DBT.
The proposed study will be a single-arm pragmatic clinical trial aiming to recruit 30 participants over the course of 12 months. Participation in this research study includes a telephone screening visit, informed consent, and baseline assessment visit (conducted via video conferencing). Following the baseline assessment there will be three follow-up assessments completed remotely at weeks 4, 8, and 12.
The adjunct intervention is Pocket Skills 2.0, a skills training app based on dialectical behavior therapy. Participants receive access to this tool in conjunction with their start of standard dialectical behavior therapy. A member of the research team will help participants sign-in for the first time. The tool can be used in any internet browser on any device connected to the internet (e.g., computer, smartphone, tablet). Participants are expected to use the app at least twice a week.
At baseline, a brief interview is completed, along with some questionnaires online. Participants are also asked about the treatment they recently started/plan to start. The interview (40-60 minutes) will involve questions about background, treatment history, and current and past psychological symptoms, and history of substance use. The questionnaires ask a range of questions related to mood, and difficulties with functioning, among other questions. These questions should only take about 15-20 minutes to answer and should be completed within 24 hours.
Participants receive requests to complete additional questionnaires online on three additional occasions (week 4, 8, and 12). Links to the questionnaire package will be sent via email (or text) and they will involve questions about well-being as well as a chance to provide open-ended feedback on the app itself. These surveys will take roughly 15-20 minutes. After 12 weeks, participants are reimbursed for their time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M6J 1H1
- Centre for Addiction and Mental Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 16 to 70
- Fluency in English.
- Understanding and willingness to comply with study requirements / capable of providing autonomous informed consent.
- Smartphone or tablet capable of downloading and running the web application, or a computer with access to the internet.
- Past year alcohol or substance use disorder
- Use of alcohol or substance in the past month.
- Starting DBT or has started DBT within the last 15 days.
- Reports at least "contemplation" levels (score of 4+) of change with respect to substance use problems.
Exclusion Criteria:
- Any known practical factors that would preclude participation (e.g., extended absences) in the study.
- Acute psychiatric (e.g., psychosis, mania) or medical condition (including acute intoxication or withdrawal requiring medical attention) that precludes participation in this study.
- Participation in another treatment/intervention study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adjunct Intervention
The intervention is called Pocket Skills 2.0, which is a web-based dialectical behavior therapy skills training (DBT-ST) intervention.
The content and material is based on the most recent Linehan (2014) DBT-ST manual.
Pocket Skills 2.0 incorporates brief lessons using videos featuring Dr. Linehan herself, exercises involving interaction with the chatbot which allow for text input and selection of responses, and the ability to gain points and unlock additional content which increases user engagement.
Pocket Skills is currently the only comprehensive and not-for-profit DBT-ST app available where the effectiveness has been evaluated in at least three research trials.
|
Dialectical behavior therapy (DBT) in its fully adherent form is a comprehensive intervention involving individual, group, and phone coaching sessions that addresses complex psychological conditions including suicidality, personality disorders, and post-traumatic stress disorder.
Evidence for briefer formats incorporating the group skills training format have been successful for many types of conditions, which includes alcohol and substance use disorders.
DBT skills training (DBT-ST) involves structured lessons for learning skills in 5 areas: mindfulness, emotion regulation, distress tolerance, interpersonal effectiveness, and addiction.
The current intervention is an internet-delivered version of DBT-ST which aims to teach people the same 5 areas of skills in an online environment with a chatbot and interactive format.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severity of Dependence Scale
Time Frame: 30 days
|
Level of dependence on most problematic substance over past 30 days.
Minimum score: 0, maximum score 15.
Higher scores mean worse outcome.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire-9 (Depression Subscale; PHQ-9)
Time Frame: 14 days
|
Level of depressive symptoms over the past 14 days.
Minimum score: 0, maximum score 27.
Higher scores mean worse outcome.
|
14 days
|
|
Generalized Anxiety Disorder-7 (GAD-7) Scale
Time Frame: 14 days
|
Level of generalized anxiety symptoms over the past 14 days.
Minimum score: 0, maximum score 21.
Higher scores mean worse outcome.
|
14 days
|
|
Difficulties in Emotion Regulation Scale, Short Form (DERS-SF; Kaufmann et al., 2015)
Time Frame: 30 days
|
Level of emotion dysregulation or the difficulty in changing unwanted emotions effectively in the past month.
Minimum score: 18, maximum score 90.
Higher scores mean worse outcome.
|
30 days
|
|
WHO Disability Assessment Schedule Short Form (WHODAS 2.0)
Time Frame: 30 days
|
Level of functional disability in the past month.
Minimum score: 0, maximum score 48.
Higher scores mean worse outcome.
|
30 days
|
|
Mindful Attention and Awareness Scale (MAAS)
Time Frame: 30 days
|
Measure of core mindfulness skills around awareness and acceptance, over the past month.
Minimum score: 0, maximum score 6 (mean score on 15 items).
Higher scores indicate more positive outcome (e.g., more mindful awareness).
|
30 days
|
|
Suicidal Behaviors Questionnaire, Revised (SBQ-R; Osman et al., 2001)
Time Frame: 30 days
|
Measure of suicidal ideation and behaviors over the past month.
Minimum score: 3, maximum score: 18.
Higher scores indicate worse outcome.
|
30 days
|
|
Risky, Impulsive, and Self-Destructive Questionnaire (RISQ)
Time Frame: 30 days
|
Measure of risky and impulsive behavior, past month.
Only subscales pertaining to sexual behavior and general reckless behavior will be used.
Minimum score: 0, Maximum score: 40.
Higher scores indicate worse outcome (e.g., more impulsive and/or risky behaviors)
|
30 days
|
|
NIDA Assist
Time Frame: 30 days
|
Assesses the frequency of non-alcohol substance use over the past month.
Minimum score per item: never used substance; maximum score per item: used substance daily or almost daily.
Higher scores indicate worse outcome (e.g., more substance use).
|
30 days
|
|
Daily Drinking Questionnaire (DDQ)
Time Frame: 30 days
|
Assesses the frequency and quantity of alcohol use and binge drinking episodes over the past month.
Minimum score: no alcoholic drinks on specific day; Maximum score: 15+ drinks on a specific day.
Higher scores indicate worse outcome (E.g., more alcoholic drinks consumed).
|
30 days
|
|
Dialectical Behavioral Therapy Ways of Coping Checklist
Time Frame: 30 days
|
Assesses the frequency and intensity of using DBT skills in the past month.
Investigators will use the DBT skills subscale only with an average score of 38 items presented.
Higher scores indicate greater use of DBT skills.
|
30 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Credibility/Expectancy Questionnaire (CEQ; Devilly & Borkovec, 2000)
Time Frame: Baseline only
|
Measure of treatment credibility and expectancy for interventions.
Minimum score: 4; Maximum score: 56; Higher scores mean participants perceive the intervention to provide expected benefits and/or improvements.
|
Baseline only
|
|
Treatment Acceptability Questionnaire (TAQ; Hunsley, 1992)
Time Frame: 30 days
|
Whether or not the treatment is seen as acceptable and helpful with respect to current symptoms/problems.
Minimum score: 6, maximum score: 42.
Higher scores indicate better treatment acceptability and positive perceptions of the treatment.
|
30 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 166/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Dialectical Behavior Therapy
-
University Hospital, Strasbourg, FranceRecruitingEncephalitis | Meningitis | Acquired Brain Injury | Cerebral Anoxia | Stroke/ Cerebrovascular Accident (Ischemic or Hemorrhagic) | Brain Tumor (After Recovery)France
-
University of WindsorRecruitingDepression | Mood Disorders | Stress | Anxiety | Depression - Major Depressive DisorderCanada
-
University Hospital, Strasbourg, FranceCompletedAutism Spectrum DisordersFrance
-
Pontificia Universidad Catolica de ChileUniversity Diego PortalesNot yet recruitingBorderline Personality DisorderChile
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedSuicide | Post-traumatic Stress Disorder | Self-injurious BehaviorUnited States
-
Fordham UniversityNot yet recruitingAntisocial Personality DisorderUnited States
-
Rutgers, The State University of New JerseyCompletedBorderline Personality DisorderUnited States
-
Masarykova UniverzitaBrno University Hospital; Masaryk UniversityCompletedBorderline Personality DisorderCzech Republic
-
University of ManitobaCompletedBorderline Personality DisorderCanada
-
Alexandria UniversityCompleted